Tag: JAMA Internal Medicine

Browse our exclusive articles!

Study Shows ChatGPT Exhibits Greater Empathy than Doctors When Answering Patient Questions

A new study from JAMA Internal Medicine has found that ChatGPT --an AI-powered chatbot-- outperforms physicians when it comes to answering patient questions. ChatGPT demonstrated higher accuracy and more empathy in its responses, making a panel of licensed healthcare professionals prefer it 79% of the time. It could prove as a useful assistant for real-world medical applications, and help physicians in providing more efficient and sophisticated care.

Can You Identify the Difference Between ChatGPT and a Doctor? A Quiz

This JAMA Internal Medicine study reveals that an AI tool, ChatGPT, is capable of outperforming physicians in answering medical questions. Bearing an impressive 79% accuracy rate and more empathetic response than doctors, it is advocated to start carrying out phase one clinical trials of AI in healthcare. Can both AI tools and doctors answer correctly? Read this article to find out!

Research: ChatGPT More Empathetic Than Doctors Toward Patients

This article focuses on a recent research study that examined the empathetic responses of both doctors and chatbot, ChatGPT. The study suggested that the chatbot responses were rated higher in terms of quality and empathy compared to responses from physicians. The study’s results may aid in creating AI assistants that can be used in clinical practice and reduce burnout of clinicians while improving patient outcomes. Despite the use of chatbots in healthcare, it’s important to prioritize the human connection when treating patients.

Popular

ChatGPT for Mac Exposed User Data, OpenAI Issues Urgent Update

Discover how ChatGPT for Mac exposed user data, leading OpenAI to issue an urgent update for improved security measures.

China Dominates Generative AI Patents, Leaving US in the Dust

China surpasses the US in generative AI patents, as WIPO reports a significant lead for China's innovative AI technologies.

Absci Corporation Grants CEO Non-Statutory Stock Option

Absci Corporation grants CEO non-statutory stock option in compliance with Nasdaq Listing Rule 5635. Stay updated on industry developments.

Apple Secures Board Seat on OpenAI, Boosting AI Partnership

Apple secures board seat with OpenAI, enhancing AI partnership. Phil Schiller's appointment signifies Apple's dedication to advancing AI technologies.

Subscribe

spot_imgspot_img